Work

EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma

Year: 2019

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz425.014

Authors: D.P. Petrylak, J.E. Rosenberg, J. Lee, J. Yonese, I. Duran, Y. Loriot, G. Sonpavde, C. Wu, E.M. Gartner, A. Melhem-Bertrandt, T. Powles

Institutions: Yale University, Memorial Sloan Kettering Cancer Center, Asan Medical Center, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Marqués de Valdecilla University Hospital, Institut Gustave Roussy, Dana-Farber Cancer Institute, Astellas Pharma (United States), Seagen (United States), Queen Mary University of London, Barts Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2991132606

Cites:

Cited by: 4

Related to: 10